TREATMENT WITH EUDRAGIT-COATED MESALAZINE TABLETS SIGNIFICANTLY IMPROVES THE WORK PRODUCTIVITY IN PATIENTS WITH MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS

(1) Agaplesion Markus Krankenhaus, Medizinische Klinik I, Frankfurt, Germany

(2) Pannónia Magánorvosi Centrum Kft, Budapest, Hungary

(3) Gastromed sc, Gastroenterology, Bialystok, Poland

(4) » Stavropol State Medical University of the Ministry of Health of the Russian Federation, Chair of propaedeutics of internal diseases, Moscow, Russian Federation

(5) National Medical University, Chair of Internal Medicine # 1, Kyiv, Ukraine

(6) Latvian Maritime Medical Hospital, Riga, Latvia

(7) Lithuanian University of Health Sciences Dept. of Gastroenterology, Gastroenterology, Vilnius, Lithuania

(8) R&D Dr. Falk Pharma GmbH, Forschung und Entwicklung, Freiburg, Germany



This item was part of UEG Week 2016

This item can be cited as: United European Gastroenterology Journal; 2016: 2 (Supplement 1)

You may be interested in:

What should be the first line treatment in UC?
English, Presentation, Clinical aspects, Ulcerative colitis, Colon, Management review, 'IBD-ology', 2013

Categorisation:

  • Format
    • Abstract
  • Year
    • 2016